Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Iceland
Iceland: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 93.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Iceland, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Iceland stood at 93.0%.
Compared with earlier readings it is down 5.1% on the previous year and down 1.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Iceland peaked at 98.0% in 2024 and was at its lowest, 0.0%, in 2000.
Iceland ranks 49th of 194 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Iceland, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 92.0% | — |
| 2004 | 89.0% | -3.3% |
| 2005 | 90.0% | +1.1% |
| 2006 | 93.0% | +3.3% |
| 2007 | 95.0% | +2.2% |
| 2008 | 94.0% | -1.1% |
| 2009 | 93.0% | -1.1% |
| 2010 | 92.0% | -1.1% |
| 2011 | 90.0% | -2.2% |
| 2012 | 97.0% | +7.8% |
| 2013 | 94.0% | -3.1% |
| 2014 | 93.0% | -1.1% |
| 2015 | 94.0% | +1.1% |
| 2016 | 95.0% | +1.1% |
| 2017 | 95.0% | +0.0% |
| 2018 | 95.0% | +0.0% |
| 2019 | 94.0% | -1.1% |
| 2020 | 93.0% | -1.1% |
| 2021 | 89.0% | -4.3% |
| 2022 | 80.0% | -10.1% |
| 2023 | 89.0% | +11.2% |
| 2024 | 98.0% | +10.1% |
| 2025 | 93.0% | -5.1% |
Iceland compared with similar countries
- Iceland's 93.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- Iceland's 93.0% is above the median for Europe & Central Asia, which is 90.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.6% | 0.0% | 95.0% | 10 |
| 2010s | 93.9% | 90.0% | 97.0% | 10 |
| 2020s | 90.3% | 80.0% | 98.0% | 6 |
Countries ranked near Iceland
More health data for Iceland
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2085)
- Heat deaths vs projected death rates, annual growth rate -0.4982 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,358 deaths per 1,000 people (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1533 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0283 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1097 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Iceland?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Iceland was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Iceland?
- The highest recorded value was 98.0% in 2024.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Iceland?
- The lowest recorded value was 0.0% in 2000.
- How does Iceland rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Iceland ranks 49th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Iceland?
- Over the last ten years it is down 1.1%. The long-run trend across the full record is rising.
- Where does this Iceland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).